Cure My Disease

Don't miss your cure!

 Log in / Sign up

Remote monitoring may keep dialysis patients safer at home

NCT ID NCT07798024

Disease control Sponsor: First Affiliated Hospital, Sun Yat-Sen University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time

Summary

This study tests whether an integrated remote patient monitoring system can improve outcomes for adults on automated peritoneal dialysis. The system collects daily treatment data from the dialysis machine and gives clinicians more frequent feedback. Researchers will compare patients using this monitoring to a historical group who did not use it, looking at rates of death, heart problems, infections, and technique failure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Integrated remote patient monitoring (IRPM), a system that collects daily treatment data from the dialysis machine and provides feedback to clinicians
What this could lead to
If it works, this could reduce complications like infections and heart problems, and help patients stay on peritoneal dialysis longer.
What could go wrong
This is a non-randomized study with a historical control group, so results may be influenced by differences between groups. The monitoring system itself does not directly treat disease, and benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 600 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Incident APD patients of multiple centesr who meet the inclusion criteria will be recruited.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Incident PD patients with age ≥18 years; * For APD-IRPM group, patients preferred to use the APD machine of Homechoice Claria®； * For Control group, patients treated with APD therapy (without RPM system) at the initiation of PD; * Signed an informed consent form. Exclusion Criteria: * Peritonitis occurred within 6 weeks before the baseline assessment. * Urinary catheter was removed or abdominal surgery was performed within 60 days before the baseline assessment. * Patients who have severe cognitive impairment or mental illness, rendering them unable to complete the follow-up.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Peritoneal dialysis (PD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Peritoneal dialysis (PD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.